PopulationsHumans

Macrovascular and Microvascular Complications in Medicare Patients with Type 2 Diabetes and Atherosclerotic Cardiovascular Disease From 2006–2021—Incidence Stratified by Sex, Age, and Race/Ethnicity

ADA Scientific Sessions 2025 Abstract

The paper

Tyler J. Dunn, Daniel M. Rotroff, Joanna G. Harton,

Sonia Kim, Xi Tan, Joshua Noone, Lin Ying Xie,

Cleveland

ADA Scientific Sessions 2025 Abstract · 13 Jun 2025

Presented at ADA Scientific Sessions 2025 · Late-breaking 1870-LB

doi.org/10.2337/db25-1870-lb

COVID-19 tied to higher dementia risk in older adults with diabetes
Frontiers in Aging Neuroscience · 4 Oct 2026
SGLT2 inhibitors link to lower dementia risk than GLP-1 drugs
Diabetes & Vascular Disease Research · 4 Oct 2026
Underweight is linked to higher kidney disease risk in diabetes
Frontiers in Endocrinology · 4 Oct 2026
SGLT2 inhibitors match GLP-1 drugs for overall kidney outcomes
Clinical Journal of the American Society of Nephrology · 4 Oct 2026